GlassScriptPhysician profile
Sanjeev M Lele
NPI 1083727366
$3,738.18
in general payments reported to CMS, 2019-2025
19 companies · $895 in 2025
The $895 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $583 · 2020: $353 · 2021: $247 · 2022: $511 · 2023: $73.42 · 2024: $1,075 · 2025: $895.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,044.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,044.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,659.52 | 2019-2025 | Argos, Unity, Rocklatan |
| Novartis Pharmaceuticals Corporation | $336.77 | 2019-2023 | |
| Allergan, INC. | $317.11 | 2019-2021 | |
| Abbvie INC. | $240.02 | 2022-2025 | |
| Astellas Pharma US INC | $192.47 | 2023-2025 | Izervay |
| Bausch & Lomb Americas INC. | $192.15 | 2023-2025 | Vyzulta, Xiidra, Miebo |
| Horizon Therapeutics Plc | $187.42 | 2020-2023 | Tepezza |
| Sun Pharmaceutical Industries INC. | $123.24 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $98.58 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $96.20 | 2022 | |
| Dompe US, INC. | $74.26 | 2025 | Oxervate |
| Thea Pharma INC. | $44.95 | 2024 | Iyuzeh |
| Aerie Pharmaceuticals, INC. | $40.49 | 2020-2021 | |
| Omeros Corporation | $38.44 | 2019 | |
| Oyster Point Pharma, INC. | $26.23 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sight Sciences, INC. | $22.27 | 2025 | Sion Surgical Instrument, Omni Surgical System |
| Kala Pharmaceuticals, INC. | $17.89 | 2022 | |
| Lilly USA, LLC | $16.60 | 2022 | |
| Spark Therapeutics, INC. | $13.57 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sanjeev Lele listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.